Quantcast

Latest Human respiratory syncytial virus Stories

2014-05-23 23:11:02

WebsiteAlive, a Houston-based online communications firm best known for its AliveChat online chat product, sponsored a team of triathletes for the 2014 Ironman Texas, held May 17, in The Woodlands, Texas. The team was raising money to fund research into RSV, a respiratory disease that kills newborns. Houston, Texas (PRWEB) May 23, 2014 On May 17, a team of five athletes from the Houston gym NonameFit competed in Ironman Texas, an endurance triathlon in The Woodlands, Texas, consisting of...

Two Separate Studies On MERS-Coronavirus Offer Better Understanding Of Newly Emerging Disease
2014-04-29 09:33:16

Lawrence LeBlond for redOrbit.com - Your Universe Online Two separate studies this week are helping scientists gain a better understanding of the dangerous Middle East respiratory syndrome (MERS) coronavirus, a disease that has sickened more than 300 people and left at least a hundred dead since it was first reported in September 2012. HUMAN ANTIBODIES The first study comes from scientists at Dana-Farber Cancer Institute who have identified natural human antibodies against the virus...

2014-04-24 23:00:33

Dr. Richard Plemper, a professor in the new Institute for Biomedical Sciences at Georgia State University, has received a five-year, $2.83 million federal grant to develop novel therapeutics against Respiratory Syncytial Virus (RSV) infection. Atlanta, GA (PRWEB) April 25, 2014 Dr. Richard Plemper, a professor in the new Institute for Biomedical Sciences at Georgia State University, has received a five-year, $2.83 million federal grant to develop novel therapeutics against Respiratory...

2014-04-21 23:02:00

Ginseng can help treat and prevent influenza and respiratory syncytial virus (RSV), a respiratory virus that infects the lungs and breathing passages, according to research findings by a scientist in Georgia State University’s new Institute for Biomedical Sciences. Atlanta, Georgia (PRWEB) April 21, 2014 Ginseng can help treat and prevent influenza and respiratory syncytial virus (RSV), a respiratory virus that infects the lungs and breathing passages, according to research findings by...

2014-04-18 12:35:28

A Dana-Farber/Boston Children's and VA Hospital/University of South Florida team created the antiviral therapy, which harnesses the power of stapled peptide and nanoparticle technologies to thwart the respiratory virus New therapies are needed to prevent and treat respiratory syncytial virus (RSV) – a potentially lethal respiratory infection that can severely affect infants, young children and the elderly. Despite a wide range of anti-RSV efforts, there are no vaccines or drugs on the...

2014-04-15 04:20:50

LONDON, April 15, 2014 /PRNewswire/ -- reViral, an antiviral drug discovery and development company, focused on diseases caused by the respiratory syncytial virus (RSV), today announced the appointment of Professor Raymond Schinazi to its Board as a Non-Executive Director, effective from 9 April 2014. Professor Schinazi has had a long and prestigious career in the industry having founded several successful biotechnology companies including Pharmasset, where he chaired...

2014-03-26 12:28:56

ANN ARBOR, Mich., March 26, 2014 /PRNewswire/ -- NanoBio Corporation today announced a licensing agreement with a subsidiary of Merck & Co., Inc., known as MSD outside the United States and Canada, for the use of its nanoemulsion (NE) adjuvant technology. Under the agreement, Merck receives exclusive rights to NanoBio's NE adjuvant for use in an intranasal respiratory syncytial virus (RSV) vaccine and non-exclusive rights for use in an intranasal seasonal influenza and/or...

2014-03-25 08:29:52

Resistance to current drugs spurs treatment innovation in influenza, respiratory syncytial virus, chlamydia and gonorrhoea LONDON, March 25, 2014 /PRNewswire/ -- The available antivirals for commonly occurring infections such as respiratory syncytial virus (RSV) and influenza are characterised by variable response, poor tolerability and suboptimal dosing regimens, limiting their regular use and efficacy. Likewise, the development of resistance to almost every recommended antibiotic...

2014-03-19 08:29:00

BD Veritor(TM) System for Rapid Detection of RSV Receives 510(k) Clearance and CLIA Waiver FRANKLIN LAKES, N.J., March 19, 2014 /PRNewswire/ -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it received 510(k) clearance and Clinical Laboratory Improvement Amendments (CLIA) waiver from the U.S. Food and Drug Administration (FDA) for nasopharyngeal swab specimens on the BD Veritor(TM) System...

2014-02-10 08:27:53

Study Aims To Evaluate Improvement in Lung Function after Treatment with NOxCureCF REHOVOT, Israel, February 10, 2014 /PRNewswire/ -- Advanced Inhalation Therapies (AIT Ltd.), a drug development company, announced today it added Schneider Children's Medical Center of Israel as the second site in its multicenter, open-label, Phase II clinical trial of NOxCureCF, a respiratory treatment for patients with cystic fibrosis (CF). Schneider Children's is the largest children's...


Latest Human respiratory syncytial virus Reference Libraries

45_372e8ab43ffc45ec313edc65d2ef1af0
2011-02-23 17:56:27

Respiratory syncytial virus (RSV) causes respiratory tract infections and is a major cause of lower respiratory tract infection and hospital visits during infancy and childhood. For premature infants and infants with congenital heart disease there is a prophylactic medication. During winter months in temperate climates there is an annual epidemic. Infection in tropical climates is most common during the rainy season. 60% of infants, in the United States, are infected during their first...

More Articles (1 articles) »
Word of the Day
lunula
  • A small crescent-shaped structure or marking, especially the white area at the base of a fingernail that resembles a half-moon.
This word is a diminutive of the Latin 'luna,' moon.
Related